External validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies

dc.contributor.authorLuu, Q.
dc.contributor.authorDay, J.
dc.contributor.authorHall, A.
dc.contributor.authorLimaye, V.
dc.contributor.authorMajor, G.
dc.date.issued2020
dc.descriptionLink to a related website: https://ard.bmj.com/content/annrheumdis/early/2020/07/28/annrheumdis-2020-217568.full.pdf, Open Access via Unpaywall
dc.description.abstractWe have read with great interest the article published by Jinnin et al, which was an external validation of sensitivity and specificity of the EULAR/ACR (European League Against Rheumatism / American College of Rheumatology) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort. The title and article claim that this is the first external validation study. While this may be true for a Japanese cohort, our intention is to alert the readers to the earlier published validation studies that preceded this and help highlight the complete body of evidence that should be considered.
dc.identifier.citationAnnals of the Rheumatic Diseases, 2020; 81(4):1-1
dc.identifier.doi10.1136/annrheumdis-2020-217568
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.orcidLimaye, V. [0000-0002-8142-9532]
dc.identifier.urihttps://hdl.handle.net/11541.2/143394
dc.language.isoen
dc.publisherB M J Group
dc.rightsCopyright 2020 Author(s) (or their employer(s))
dc.source.urihttps://doi.org/10.1136/annrheumdis-2020-217568
dc.subjectHumans
dc.subjectMyositis
dc.subjectRheumatic Diseases
dc.subjectSensitivity and Specificity
dc.subjectRheumatology
dc.subjectJapan
dc.titleExternal validation of EULAR/ACR classification criteria for idiopathic inflammatory myopathies
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9916403508101831

Files

Collections